Loading content…
Affiliate-supportedIndependent editorialWe never sell medicationSee how
South · Tennessee
Local context for Wegovy, Ozempic, Mounjaro, and Zepbound in Memphis (620,000 residents, 1,330,000 metro). St. Jude anchors pediatric specialty care; TennCare covers T2D GLP-1s with prior auth despite no full ACA expansion.
Availability and prices vary by pharmacy and date. We do not maintain real-time per-pharmacy stock data. Confirm with pharmacies directly.
Wegovy
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for chronic weight management in adults and adolescents.
Wegovy in Memphis →
Ozempic
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for adults with type 2 diabetes.
Ozempic in Memphis →
Mounjaro
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for adults with type 2 diabetes.
Mounjaro in Memphis →
Zepbound
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for chronic weight management and obstructive sleep apnea.
Zepbound in Memphis →
Memphis is a south-region city with a population of 620,000 (1,330,000 in the broader metropolitan area). Tennessee has not expanded Medicaid under the Affordable Care Act, which limits low-income adults' access to GLP-1 coverage; many uninsured residents rely on manufacturer savings programs or compounded options instead.
Statewide, notable health systems include Vanderbilt Health, Methodist Le Bonheur Healthcare.
Tennessee's Medicaid program is TennCare. Coverage rules for GLP-1 medications vary by drug and indication; see our pricing by state map and payer-coverage guides for details.
Cities of similar size with comparable healthcare markets.